EARNEST Partners’s Chemours CC Stock Holding History

EARNEST Partners’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-112	Closed	-$4K	–	1176
2019 Q1	$4K	Hold	112	–	–	﹤0.01%	802
2018 Q4	$3K	Hold	112	–	–	﹤0.01%	841
2018 Q3	$4K	Hold	112	–	–	﹤0.01%	837
2018 Q2	$5K	Hold	112	–	–	﹤0.01%	745
2018 Q1	$5K	Hold	112	–	–	﹤0.01%	732
2017 Q4	$6K	Buy	+112	New	+$5.87K	﹤0.01%	672

Other funds holding CC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

EARNEST Partners's CC Position: Q2 2019 in Review

EARNEST Partners sold out of Chemours (CC) in Q2 2019, closing a stake of 112 shares — an estimated $4K sold.

EARNEST Partners first reported a position in CC in Q4 2017 and held it in 6 quarters. The position peaked at $6K in Q4 2017. 488 funds tracked by Wall St. Rank hold CC as of Q2 2019.

EARNEST Partners reported no remaining Chemours position as of Q2 2019 after selling out during the quarter.
EARNEST Partners sold 112 Chemours shares in Q2 2019, an estimated $4K.
EARNEST Partners first reported a position in Chemours in Q4 2017 and held it in 6 quarters.
EARNEST Partners's Chemours position peaked at $6K in Q4 2017.
488 funds tracked by Wall St. Rank held Chemours as of Q2 2019.

Based on EARNEST Partners's 13F filing for Q2 2019, filed 13 Aug 2019.